NITROGLYCERIN

NITROGLYCERIN was reported 54026 times

NITROGLYCERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 54 0.5625
1 VAGINAL FLATULENCE 163 0.5380
2 ANTACID THERAPY 48 0.3692
3 SLEEP DISORDER THERAPY 53 0.2677
4 CONGENITAL HIATUS HERNIA 57 0.2500
5 AMAUROSIS FUGAX 248 0.2303
6 PROLONGED EXPIRATION 58 0.2214
7 MALIGNANT MELANOMA STAGE 0 44 0.2105
8 SEDATION COMPLICATION 468 0.1832
9 ANTICOAGULANT THERAPY 52 0.1831
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 169 0.1823
11 ANALGESIC THERAPY 55 0.1713
12 DRUG THERAPY 51 0.1504
13 CREATININE RENAL CLEARANCE DECREASED 499 0.1246
14 MULTIPLE DRUG THERAPY 92 0.1220
15 REVERSIBLE AIRWAYS OBSTRUCTION 52 0.1024
16 FEMALE GENITAL TRACT FISTULA 174 0.1018
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 101 0.0951
18 HYPERPARATHYROIDISM SECONDARY 227 0.0905
19 CARDIOSPASM 50 0.0896
20 CREATININE RENAL CLEARANCE INCREASED 66 0.0882
21 BRAIN SCAN ABNORMAL 49 0.0878
22 NEPHROGENIC ANAEMIA 401 0.0865
23 TOTAL LUNG CAPACITY DECREASED 128 0.0801
24 CEREBRAL ARTERY THROMBOSIS 41 0.0798
25 RADICULOPATHY 210 0.0796
26 OESOPHAGEAL SPASM 134 0.0727
27 ISCHAEMIC CARDIOMYOPATHY 205 0.0668
28 PALMOPLANTAR KERATODERMA 47 0.0648
29 ANGINA UNSTABLE 418 0.0642
30 PROCTITIS 173 0.0617
31 CHRONIC SINUSITIS 228 0.0607
32 DYSPNOEA PAROXYSMAL NOCTURNAL 43 0.0590
33 ESSENTIAL HYPERTENSION 100 0.0546
34 PRINZMETAL ANGINA 53 0.0533
35 REBOUND ACID HYPERSECRETION 161 0.0532
36 RALES 305 0.0525
37 URINARY TRACT DISORDER 227 0.0504
38 LUNG OPACITY 131 0.0497
39 LEFT ATRIAL DILATATION 62 0.0486
40 PLEURITIC PAIN 133 0.0481
41 BLOOD CALCIUM DECREASED 540 0.0480
42 CORONARY ARTERY DISEASE 1413 0.0466
43 CORONARY ARTERIAL STENT INSERTION 236 0.0465
44 LABILE BLOOD PRESSURE 53 0.0446
45 OBSTRUCTIVE SLEEP APNOEA SYNDROME 65 0.0446
46 ANGINA PECTORIS 1269 0.0442
47 SICK SINUS SYNDROME 49 0.0426
48 ORTHOSTATIC HYPOTENSION 727 0.0417
49 ORTHOPNOEA 132 0.0414
50 HAEMORRHAGIC STROKE 323 0.0413
51 ARTERIOSCLEROSIS CORONARY ARTERY 268 0.0404
52 ANGIOPLASTY 58 0.0388
53 CARDIOACTIVE DRUG LEVEL INCREASED 50 0.0380
54 PERIPHERAL VASCULAR DISORDER 190 0.0368
55 ACUTE MYOCARDIAL INFARCTION 1039 0.0352
56 DILATATION ATRIAL 41 0.0351
57 CORONARY ARTERY STENOSIS 175 0.0348
58 HYPERLIPIDAEMIA 408 0.0341
59 CAROTID ARTERY DISEASE 43 0.0338
60 END STAGE RENAL DISEASE 616 0.0337
61 VENTRICULAR DYSFUNCTION 87 0.0335
62 INTERMITTENT CLAUDICATION 53 0.0334
63 ARTERIOSPASM CORONARY 134 0.0334
64 HYPERPHOSPHATAEMIA 70 0.0325
65 ECHOCARDIOGRAM ABNORMAL 45 0.0321
66 HAEMORRHAGIC ANAEMIA 140 0.0318
67 DIASTOLIC DYSFUNCTION 97 0.0314
68 RENAL INJURY 924 0.0311
69 TROPONIN INCREASED 236 0.0310
70 CORONARY ARTERY OCCLUSION 424 0.0309
71 COLONIC POLYP 51 0.0309
72 ATRIAL TACHYCARDIA 63 0.0300
73 MYOCARDIAL ISCHAEMIA 341 0.0299
74 OESOPHAGEAL PAIN 117 0.0296
75 CAROTID ARTERY STENOSIS 103 0.0295
76 BRONCHIECTASIS 198 0.0294
77 MITRAL VALVE INCOMPETENCE 331 0.0292
78 THERAPEUTIC AGENT TOXICITY 96 0.0288
79 DILATATION VENTRICULAR 60 0.0285
80 LEFT VENTRICULAR HYPERTROPHY 118 0.0275
81 CORONARY ARTERY THROMBOSIS 55 0.0273
82 MULTI-ORGAN FAILURE 471 0.0272
83 CARDIOMEGALY 332 0.0270
84 FEAR 716 0.0266
85 LYMPHOEDEMA 183 0.0264
86 AORTIC STENOSIS 92 0.0264
87 BENIGN PROSTATIC HYPERPLASIA 136 0.0263
88 TRICUSPID VALVE INCOMPETENCE 209 0.0263
89 SUPRAVENTRICULAR EXTRASYSTOLES 88 0.0260
90 KYPHOSIS 46 0.0260
91 SPUTUM DISCOLOURED 246 0.0259
92 NON-CARDIAC CHEST PAIN 82 0.0259
93 MACULAR DEGENERATION 305 0.0255
94 MULTIPLE INJURIES 160 0.0254
95 ANHEDONIA 665 0.0253
96 CAROTID ARTERY OCCLUSION 92 0.0252
97 DIABETIC NEUROPATHY 123 0.0248
98 CONDUCTION DISORDER 45 0.0245
99 BREATH SOUNDS ABNORMAL 119 0.0241
100 OCULAR DISCOMFORT 268 0.0238
101 LEFT VENTRICULAR FAILURE 82 0.0238
102 AORTIC ARTERIOSCLEROSIS 61 0.0237
103 ACUTE CORONARY SYNDROME 196 0.0236
104 OBSTRUCTIVE AIRWAYS DISORDER 263 0.0236
105 ECONOMIC PROBLEM 358 0.0236
106 CARDIAC FAILURE CONGESTIVE 1891 0.0235
107 RENAL FAILURE CHRONIC 181 0.0235
108 VENTRICULAR HYPERTROPHY 59 0.0235
109 PRURITUS GENITAL 55 0.0233
110 BUNDLE BRANCH BLOCK LEFT 99 0.0233
111 LOBAR PNEUMONIA 43 0.0232
112 GENERALISED OEDEMA 285 0.0230
113 HYPERTENSIVE HEART DISEASE 43 0.0230
114 ATRIOVENTRICULAR BLOCK FIRST DEGREE 98 0.0226
115 PRODUCT SOLUBILITY ABNORMAL 114 0.0226
116 CARDIAC MURMUR 195 0.0225
117 AREFLEXIA 60 0.0225
118 CHRONIC KIDNEY DISEASE 1699 0.0223
119 BLOOD CALCIUM INCREASED 196 0.0223
120 AORTIC VALVE INCOMPETENCE 95 0.0223
121 VENTRICULAR HYPOKINESIA 71 0.0221
122 ARTERIOSCLEROSIS 208 0.0221
123 RENAL FUNCTION TEST ABNORMAL 102 0.0219
124 VENTRICULAR EXTRASYSTOLES 224 0.0215
125 DYSLIPIDAEMIA 109 0.0214
126 CORONARY ARTERY BYPASS 123 0.0214
127 BLOOD PRESSURE DIASTOLIC ABNORMAL 54 0.0212
128 RENAL NEOPLASM 45 0.0212
129 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 70 0.0211
130 SEDATION 552 0.0211
131 ARTERIAL OCCLUSIVE DISEASE 163 0.0207
132 HYPERCHOLESTEROLAEMIA 198 0.0205
133 FEAR OF DEATH 46 0.0204
134 ASPIRATION 224 0.0204
135 VENTRICULAR TACHYCARDIA 337 0.0204
136 CATHETERISATION CARDIAC 90 0.0203
137 ATELECTASIS 194 0.0201
138 LOWER GASTROINTESTINAL HAEMORRHAGE 148 0.0200
139 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 101 0.0199
140 NEPHROGENIC SYSTEMIC FIBROSIS 60 0.0198
141 MYOCARDIAL INFARCTION 3430 0.0196
142 DIABETIC NEPHROPATHY 43 0.0195
143 PRESYNCOPE 474 0.0195
144 SLEEP APNOEA SYNDROME 364 0.0191
145 RENAL FAILURE 2531 0.0190
146 BLOOD LOSS ANAEMIA 43 0.0190
147 STENT PLACEMENT 153 0.0190
148 LEFT VENTRICULAR DYSFUNCTION 126 0.0188
149 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 41 0.0186
150 DIVERTICULUM 131 0.0184
151 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 75 0.0184
152 HYPOVOLAEMIA 107 0.0183
153 BLOOD CHLORIDE DECREASED 47 0.0182
154 VENTRICULAR FIBRILLATION 201 0.0181
155 DIVERTICULUM INTESTINAL 77 0.0176
156 VAGINAL DISCHARGE 177 0.0175
157 CREPITATIONS 52 0.0174
158 PARAESTHESIA ORAL 251 0.0174
159 BLOOD PRESSURE SYSTOLIC ABNORMAL 43 0.0174
160 ATRIAL FLUTTER 138 0.0173
161 INJURY 1213 0.0172
162 CARDIAC VALVE DISEASE 98 0.0171
163 RENAL CYST 135 0.0170
164 HEART INJURY 42 0.0169
165 BRAIN NATRIURETIC PEPTIDE INCREASED 52 0.0169
166 LUNG CONSOLIDATION 47 0.0168
167 HIATUS HERNIA 217 0.0167
168 HEAD DISCOMFORT 294 0.0166
169 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 866 0.0166
170 PEPTIC ULCER 55 0.0166
171 HAEMATEMESIS 420 0.0166
172 CARDIOMYOPATHY 244 0.0165
173 DEPRESSIVE SYMPTOM 58 0.0164
174 CHEST PAIN 3043 0.0164
175 PERIPHERAL ISCHAEMIA 67 0.0164
176 ORAL CANDIDIASIS 216 0.0164
177 TENOSYNOVITIS 45 0.0163
178 VASCULAR GRAFT 47 0.0163
179 RENAL FAILURE ACUTE 688 0.0162
180 HIGH DENSITY LIPOPROTEIN DECREASED 54 0.0162
181 DEPRESSED LEVEL OF CONSCIOUSNESS 636 0.0161
182 ECCHYMOSIS 109 0.0159
183 SINUS BRADYCARDIA 153 0.0158
184 ATRIOVENTRICULAR BLOCK SECOND DEGREE 48 0.0158
185 COGNITIVE DISORDER 738 0.0158
186 BLOOD PHOSPHORUS INCREASED 43 0.0157
187 HAEMOPTYSIS 439 0.0157
188 ISCHAEMIA 72 0.0156
189 INTERNATIONAL NORMALISED RATIO DECREASED 63 0.0155
190 SPINAL OSTEOARTHRITIS 135 0.0154
191 ATRIOVENTRICULAR BLOCK 117 0.0151
192 RESPIRATORY SYMPTOM 43 0.0151
193 TENSION HEADACHE 65 0.0151
194 BUNDLE BRANCH BLOCK RIGHT 69 0.0150
195 ELECTROCARDIOGRAM ABNORMAL 117 0.0149
196 FLANK PAIN 136 0.0145
197 TRANSIENT ISCHAEMIC ATTACK 489 0.0145
198 FULL BLOOD COUNT ABNORMAL 153 0.0145
199 PULMONARY MASS 215 0.0144
200 ACUTE PULMONARY OEDEMA 80 0.0142
201 HEPARIN-INDUCED THROMBOCYTOPENIA 70 0.0142
202 CONGESTIVE CARDIOMYOPATHY 59 0.0141
203 ANXIETY DISORDER 47 0.0141
204 CEREBRAL ATROPHY 56 0.0140
205 METABOLIC ENCEPHALOPATHY 42 0.0140
206 HAEMATURIA 479 0.0140
207 CEREBROVASCULAR DISORDER 42 0.0139
208 RENAL TUBULAR NECROSIS 136 0.0139
209 DIABETIC RETINOPATHY 47 0.0138
210 DYSPNOEA EXERTIONAL 519 0.0138
211 UPPER GASTROINTESTINAL HAEMORRHAGE 231 0.0137
212 PROTHROMBIN TIME PROLONGED 82 0.0137
213 BLOOD TEST ABNORMAL 191 0.0136
214 CARDIOGENIC SHOCK 195 0.0136
215 DIPLOPIA 352 0.0135
216 GASTROINTESTINAL HAEMORRHAGE 1120 0.0134
217 CHEST X-RAY ABNORMAL 41 0.0134
218 SPINAL COLUMN STENOSIS 63 0.0133
219 GOUT 237 0.0132
220 ALTERED STATE OF CONSCIOUSNESS 285 0.0131
221 IRON DEFICIENCY ANAEMIA 121 0.0131
222 RECTAL HAEMORRHAGE 561 0.0130
223 HYPERKERATOSIS 72 0.0130
224 BLOOD UREA INCREASED 217 0.0129
225 ORGAN FAILURE 52 0.0129
226 VENTRICULAR ARRHYTHMIA 47 0.0128
227 ASCITES 376 0.0128
228 AORTIC ANEURYSM 97 0.0127
229 BRADYCARDIA 673 0.0127
230 APPETITE DISORDER 84 0.0127
231 MYASTHENIA GRAVIS 102 0.0126
232 PHOTOPHOBIA 236 0.0125
233 UNEVALUABLE EVENT 943 0.0125
234 ATRIAL FIBRILLATION 1212 0.0124
235 ATRIOVENTRICULAR BLOCK COMPLETE 83 0.0124
236 AZOTAEMIA 49 0.0123
237 PULMONARY FIBROSIS 233 0.0121
238 HYPERVOLAEMIA 60 0.0121
239 RHINITIS ALLERGIC 54 0.0121
240 HYPOPHOSPHATAEMIA 89 0.0120
241 PULMONARY OEDEMA 538 0.0120
242 BALANCE DISORDER 1035 0.0120
243 CARDIAC PACEMAKER INSERTION 71 0.0119
244 SLEEP TERROR 50 0.0119
245 DIZZINESS POSTURAL 115 0.0118
246 HYPOMAGNESAEMIA 165 0.0118
247 SUPRAVENTRICULAR TACHYCARDIA 113 0.0118
248 IRON DEFICIENCY 53 0.0118
249 RESPIRATION ABNORMAL 81 0.0117
250 CARDIAC FAILURE ACUTE 78 0.0117
251 HYPOTENSION 2336 0.0116
252 EMPHYSEMA 117 0.0116
253 PULSE ABSENT 55 0.0116
254 MICTURITION URGENCY 132 0.0115
255 CARDIO-RESPIRATORY ARREST 483 0.0115
256 LUNG INFILTRATION 102 0.0115
257 HAEMORRHOIDAL HAEMORRHAGE 56 0.0115
258 HYPOXIA 403 0.0114
259 INTERNATIONAL NORMALISED RATIO INCREASED 326 0.0114
260 RENAL IMPAIRMENT 952 0.0113
261 EXTRASYSTOLES 78 0.0112
262 GASTRITIS EROSIVE 52 0.0111
263 ACUTE KIDNEY INJURY 1707 0.0111
264 HYPERKALAEMIA 391 0.0111
265 EJECTION FRACTION DECREASED 173 0.0111
266 TINNITUS 507 0.0110
267 WHEEZING 651 0.0110
268 OSTEOARTHRITIS 460 0.0108
269 PULMONARY HYPERTENSION 225 0.0108
270 CARDIAC FAILURE CHRONIC 46 0.0108
271 INTERVERTEBRAL DISC DISORDER 46 0.0108
272 GASTROOESOPHAGEAL REFLUX DISEASE 864 0.0107
273 NEPHROPATHY 100 0.0107
274 TUBULOINTERSTITIAL NEPHRITIS 199 0.0106
275 FIBROMYALGIA 257 0.0106
276 POST PROCEDURAL HAEMORRHAGE 123 0.0106
277 DIABETES MELLITUS INADEQUATE CONTROL 187 0.0106
278 SYNCOPE 1051 0.0105
279 OBESITY 167 0.0105
280 HEART RATE IRREGULAR 236 0.0104
281 COAGULOPATHY 174 0.0104
282 POLYP 68 0.0104
283 CARDIAC DISORDER 971 0.0104
284 INTERVERTEBRAL DISC DEGENERATION 96 0.0104
285 BLOOD MAGNESIUM DECREASED 89 0.0103
286 SUBARACHNOID HAEMORRHAGE 105 0.0103
287 PULSELESS ELECTRICAL ACTIVITY 43 0.0103
288 COLITIS ISCHAEMIC 69 0.0102
289 PLEURAL EFFUSION 621 0.0102
290 HAEMORRHOIDS 199 0.0102
291 EXOSTOSIS 93 0.0102
292 BLINDNESS 414 0.0101
293 CLOSTRIDIUM DIFFICILE COLITIS 107 0.0101
294 MOBILITY DECREASED 725 0.0101
295 ABDOMINAL HERNIA 46 0.0101
296 ACUTE RESPIRATORY FAILURE 194 0.0101
297 BLADDER DISORDER 100 0.0101
298 OEDEMA PERIPHERAL 1226 0.0100
299 BLOOD PRESSURE DIASTOLIC DECREASED 73 0.0099
300 BLOOD PRESSURE SYSTOLIC INCREASED 192 0.0098
301 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87 0.0098
302 DUODENAL ULCER 69 0.0098
303 ULCER 155 0.0097
304 CYSTITIS 310 0.0097
305 URINE OUTPUT DECREASED 85 0.0097
306 PRODUCTIVE COUGH 464 0.0097
307 CARDIAC FAILURE 773 0.0096
308 UPPER RESPIRATORY TRACT INFECTION 442 0.0096
309 BLOOD CREATININE INCREASED 620 0.0095
310 HEART RATE DECREASED 333 0.0095
311 BLOOD PRESSURE SYSTOLIC DECREASED 43 0.0094
312 FLUID RETENTION 479 0.0094
313 GASTRITIS 244 0.0093
314 INTESTINAL ISCHAEMIA 51 0.0093
315 HAEMODIALYSIS 77 0.0092
316 HAEMATOMA 235 0.0091
317 FALL 3008 0.0090
318 IMPAIRED GASTRIC EMPTYING 123 0.0090
319 HEMIPLEGIA 75 0.0090
320 BLOOD URIC ACID INCREASED 52 0.0090
321 FREQUENT BOWEL MOVEMENTS 243 0.0090
322 HYPERTENSIVE CRISIS 100 0.0090
323 MUSCULOSKELETAL CHEST PAIN 139 0.0090
324 RHABDOMYOLYSIS 373 0.0089
325 ANAEMIA 1698 0.0089
326 CHEST DISCOMFORT 911 0.0089
327 SKIN ABRASION 42 0.0089
328 TRANSAMINASES INCREASED 197 0.0089
329 INTERNAL HAEMORRHAGE 101 0.0088
330 DECUBITUS ULCER 72 0.0088
331 TYPE 1 DIABETES MELLITUS 53 0.0088
332 PROCEDURAL PAIN 244 0.0088
333 NOCTURIA 106 0.0087
334 BRONCHITIS 646 0.0087
335 HAEMATOCRIT DECREASED 173 0.0087
336 HOSPICE CARE 86 0.0087
337 TYPE 2 DIABETES MELLITUS 292 0.0087
338 CONSTIPATION 1889 0.0087
339 LEUKOCYTOSIS 156 0.0086
340 MALNUTRITION 96 0.0086
341 ANGIOPATHY 48 0.0086
342 BLOOD POTASSIUM INCREASED 139 0.0086
343 LOWER RESPIRATORY TRACT INFECTION 389 0.0085
344 DIABETES MELLITUS 652 0.0085
345 FLUID OVERLOAD 124 0.0085
346 VARICOSE VEIN 44 0.0085
347 PULMONARY CONGESTION 112 0.0085
348 BLOOD TRIGLYCERIDES INCREASED 150 0.0085
349 GANGRENE 51 0.0085
350 MENTAL STATUS CHANGES 235 0.0085
351 ISCHAEMIC STROKE 151 0.0085
352 BLOOD ALBUMIN DECREASED 67 0.0084
353 ANEURYSM 42 0.0084
354 POST PROCEDURAL COMPLICATION 162 0.0084
355 LIVER FUNCTION TEST INCREASED 180 0.0084
356 COLITIS 317 0.0084
357 FAILURE TO THRIVE 43 0.0083
358 ULCER HAEMORRHAGE 56 0.0083
359 CARDIAC ARREST 678 0.0082
360 CARPAL TUNNEL SYNDROME 114 0.0081
361 HYPOGLYCAEMIA 393 0.0081
362 OESOPHAGITIS 88 0.0080
363 JOINT INJURY 172 0.0080
364 GASTRIC ULCER 153 0.0080
365 MIDDLE INSOMNIA 150 0.0080
366 TRANSFUSION 84 0.0080
367 EYE PAIN 452 0.0080
368 VITAMIN D DEFICIENCY 78 0.0080
369 TENDON DISORDER 52 0.0080
370 RIB FRACTURE 164 0.0080
371 HAEMATOCHEZIA 439 0.0079
372 GLUCOSE TOLERANCE IMPAIRED 47 0.0079
373 GASTRIC ULCER HAEMORRHAGE 44 0.0079
374 SCOLIOSIS 49 0.0079
375 COMA 376 0.0079
376 RESPIRATORY RATE INCREASED 70 0.0079
377 HYPOKALAEMIA 363 0.0079
378 FACIAL PAIN 70 0.0078
379 BLOOD PRESSURE FLUCTUATION 188 0.0078
380 HALLUCINATION 590 0.0078
381 DRUG INTERACTION 1237 0.0078
382 TORSADE DE POINTES 61 0.0078
383 MELAENA 171 0.0078
384 DYSPNOEA 4351 0.0077
385 RESPIRATORY DISTRESS 212 0.0077
386 EXERCISE TOLERANCE DECREASED 44 0.0076
387 CARDIOVASCULAR DISORDER 194 0.0076
388 EMOTIONAL DISTRESS 922 0.0076
389 WALKING AID USER 50 0.0076
390 SKIN ULCER 196 0.0076
391 MYOSITIS 68 0.0076
392 HEPATIC STEATOSIS 140 0.0075
393 SHOCK HAEMORRHAGIC 61 0.0075
394 LOCALISED INFECTION 181 0.0075
395 BODY HEIGHT DECREASED 80 0.0075
396 BLOOD CREATINE PHOSPHOKINASE INCREASED 215 0.0075
397 CELLULITIS 376 0.0075
398 CIRCULATORY COLLAPSE 127 0.0074
399 BLOOD PRESSURE DECREASED 495 0.0074
400 OSTEOPENIA 113 0.0074
401 BLOOD PRESSURE INCREASED 1132 0.0074
402 TACHYCARDIA 657 0.0074
403 INCREASED TENDENCY TO BRUISE 68 0.0074
404 MAJOR DEPRESSION 54 0.0074
405 SEPSIS 821 0.0074
406 ANXIETY 2092 0.0073
407 NEUROLOGICAL SYMPTOM 42 0.0073
408 SUBDURAL HAEMATOMA 105 0.0073
409 INTERVERTEBRAL DISC PROTRUSION 160 0.0073
410 PALLOR 199 0.0073
411 MYOPATHY 63 0.0073
412 FACIAL PARALYSIS 62 0.0073
413 BURSITIS 88 0.0072
414 JOINT EFFUSION 50 0.0072
415 DYSPEPSIA 710 0.0072
416 ASTHMA 815 0.0072
417 CONTUSION 694 0.0072
418 REFUSAL OF TREATMENT BY PATIENT 47 0.0072
419 BLOOD SODIUM DECREASED 135 0.0072
420 CEREBROVASCULAR ACCIDENT 1213 0.0072
421 RESTLESS LEGS SYNDROME 130 0.0071
422 HEAD INJURY 226 0.0071
423 SPINAL COMPRESSION FRACTURE 59 0.0071
424 BODY TEMPERATURE DECREASED 70 0.0071
425 ARRHYTHMIA 336 0.0071
426 OLIGURIA 44 0.0071
427 LARGE INTESTINE POLYP 49 0.0071
428 RESPIRATORY FAILURE 513 0.0070
429 TENDERNESS 73 0.0070
430 CARDIAC FLUTTER 45 0.0070
431 POLYURIA 57 0.0070
432 LIMB INJURY 189 0.0070
433 MUSCLE STRAIN 60 0.0069
434 BLOOD COUNT ABNORMAL 105 0.0069
435 EPISTAXIS 518 0.0069
436 CHOLELITHIASIS 227 0.0069
437 SINUS TACHYCARDIA 98 0.0069
438 HYPERTENSION 1460 0.0069
439 SEASONAL ALLERGY 97 0.0068
440 BLOOD PRESSURE INADEQUATELY CONTROLLED 41 0.0068
441 INCONTINENCE 72 0.0068
442 COUGH 1906 0.0068
443 BLOOD PRESSURE ABNORMAL 135 0.0068
444 ANKLE FRACTURE 105 0.0068
445 HYPONATRAEMIA 382 0.0068
446 DIVERTICULITIS 187 0.0067
447 HYPERHIDROSIS 869 0.0067
448 LOW DENSITY LIPOPROTEIN INCREASED 52 0.0067
449 OSTEOPOROSIS 276 0.0067
450 COLD SWEAT 118 0.0067
451 EOSINOPHILIA 117 0.0067
452 NECK PAIN 371 0.0066
453 ASTHENIA 2490 0.0066
454 ROTATOR CUFF SYNDROME 85 0.0066
455 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 112 0.0066
456 WOUND INFECTION 72 0.0066
457 BLOOD CHOLESTEROL INCREASED 306 0.0066
458 ABDOMINAL PAIN 1524 0.0065
459 DEHYDRATION 872 0.0065
460 PERICARDIAL EFFUSION 151 0.0065
461 MULTIPLE ALLERGIES 51 0.0065
462 FAECES DISCOLOURED 140 0.0065
463 PNEUMONIA 2087 0.0064
464 HALLUCINATION, VISUAL 136 0.0064
465 SINUS CONGESTION 87 0.0064
466 GLAUCOMA 124 0.0064
467 BACTERIAL INFECTION 120 0.0064
468 GLOMERULAR FILTRATION RATE DECREASED 79 0.0064
469 ABDOMINAL PAIN UPPER 1321 0.0064
470 NEURALGIA 156 0.0064
471 DEMENTIA 179 0.0064
472 CARDIAC OPERATION 55 0.0064
473 UNRESPONSIVE TO STIMULI 165 0.0064
474 RETCHING 136 0.0064
475 JOINT RANGE OF MOTION DECREASED 85 0.0063
476 DEPRESSION 1441 0.0063
477 SPLENOMEGALY 74 0.0063
478 HAEMOGLOBIN DECREASED 647 0.0063
479 PALPITATIONS 737 0.0063
480 BLOOD POTASSIUM DECREASED 189 0.0063
481 HYPERGLYCAEMIA 229 0.0063
482 OXYGEN SATURATION DECREASED 353 0.0063
483 CYANOSIS 98 0.0062
484 DYSURIA 229 0.0062
485 CHOLECYSTITIS 74 0.0062
486 DIZZINESS 3077 0.0062
487 PRODUCT ADMINISTRATION INTERRUPTED 48 0.0061
488 RESPIRATORY TRACT CONGESTION 97 0.0061
489 GASTROENTERITIS 89 0.0061
490 OEDEMA 330 0.0061
491 HEMIPARESIS 103 0.0061
492 HYPERTHYROIDISM 88 0.0061
493 MUSCULOSKELETAL PAIN 318 0.0061
494 PAIN 3726 0.0061
495 GROIN PAIN 53 0.0060
496 WEIGHT FLUCTUATION 63 0.0060
497 ACTIVITIES OF DAILY LIVING IMPAIRED 119 0.0060
498 PURPURA 53 0.0060
499 URINARY TRACT INFECTION 1014 0.0059
500 MYALGIA 1003 0.0059
501 BACK PAIN 1369 0.0059
502 PROCEDURAL COMPLICATION 45 0.0059
503 AMNESIA 381 0.0059
504 HYPOKINESIA 85 0.0058
505 CHILLS 686 0.0058
506 ADRENAL INSUFFICIENCY 71 0.0058
507 LACERATION 55 0.0058
508 URINARY INCONTINENCE 173 0.0058
509 UPPER-AIRWAY COUGH SYNDROME 48 0.0058
510 BLOOD IRON DECREASED 69 0.0058
511 CONCUSSION 45 0.0058
512 MUSCLE DISORDER 47 0.0058
513 FOOT FRACTURE 110 0.0058
514 DELIRIUM 201 0.0058
515 ERYTHEMA MULTIFORME 54 0.0058
516 SMALL INTESTINAL OBSTRUCTION 71 0.0058
517 VASCULITIS 67 0.0057
518 RENAL DISORDER 267 0.0057
519 SKIN LACERATION 62 0.0057
520 VISION BLURRED 780 0.0057
521 ANOREXIA 73 0.0057
522 CHOKING 110 0.0056
523 DIALYSIS 80 0.0056
524 UROSEPSIS 52 0.0056
525 PULMONARY HAEMORRHAGE 44 0.0056
526 HYPERSOMNIA 161 0.0056
527 BACK INJURY 61 0.0056
528 STAPHYLOCOCCAL INFECTION 185 0.0056
529 SKIN CANCER 120 0.0056
530 HAEMORRHAGE INTRACRANIAL 83 0.0055
531 BONE DISORDER 101 0.0055
532 BLOOD URINE PRESENT 105 0.0055
533 APNOEA 43 0.0055
534 MULTIPLE ORGAN DYSFUNCTION SYNDROME 156 0.0055
535 CONFUSIONAL STATE 890 0.0055
536 URINARY RETENTION 183 0.0055
537 PERICARDITIS 92 0.0055
538 MUSCULOSKELETAL DISCOMFORT 94 0.0055
539 CHROMATURIA 123 0.0054
540 HYPOCALCAEMIA 103 0.0054
541 WEIGHT DECREASED 1518 0.0054
542 FOOT DEFORMITY 60 0.0054
543 OSTEOMYELITIS 98 0.0054
544 INFUSION RELATED REACTION 357 0.0054
545 FULL BLOOD COUNT DECREASED 108 0.0054
546 KIDNEY INFECTION 105 0.0053
547 MUSCULAR WEAKNESS 608 0.0053
548 ANURIA 46 0.0053
549 LOSS OF CONSCIOUSNESS 684 0.0053
550 DECREASED APPETITE 1238 0.0053
551 PERIPHERAL COLDNESS 73 0.0053
552 SPINAL FRACTURE 106 0.0053
553 MUSCULOSKELETAL STIFFNESS 463 0.0053
554 AGITATION 387 0.0053
555 HEART RATE INCREASED 521 0.0053
556 WRIST FRACTURE 63 0.0053
557 ELECTROLYTE IMBALANCE 61 0.0052
558 PROSTATIC SPECIFIC ANTIGEN INCREASED 72 0.0052
559 ANAL INCONTINENCE 47 0.0052
560 DISORIENTATION 207 0.0052
561 WOUND 146 0.0052
562 GASTRIC HAEMORRHAGE 60 0.0052
563 COLITIS ULCERATIVE 233 0.0052
564 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 370 0.0052
565 BLOOD GLUCOSE FLUCTUATION 57 0.0052
566 SINUS DISORDER 103 0.0052
567 HYPOTHYROIDISM 166 0.0052
568 ASPARTATE AMINOTRANSFERASE INCREASED 274 0.0052
569 CATARACT 307 0.0052
570 APPENDICITIS 48 0.0051
571 POLLAKIURIA 214 0.0051
572 DYSPHAGIA 487 0.0051
573 DISABILITY 101 0.0051
574 DYSARTHRIA 192 0.0051
575 LIVER FUNCTION TEST ABNORMAL 148 0.0051
576 SCAR 87 0.0051
577 TREMOR 843 0.0051
578 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 87 0.0051
579 RED BLOOD CELL COUNT DECREASED 145 0.0051
580 RESPIRATORY TRACT INFECTION 132 0.0051
581 BASAL CELL CARCINOMA 79 0.0051
582 PULMONARY EMBOLISM 481 0.0051
583 GALLBLADDER DISORDER 90 0.0050
584 SPINAL PAIN 59 0.0050
585 LABORATORY TEST ABNORMAL 148 0.0050
586 DECREASED ACTIVITY 54 0.0050
587 WHITE BLOOD CELL COUNT INCREASED 192 0.0050
588 CEREBRAL HAEMORRHAGE 179 0.0050
589 MIGRAINE 476 0.0050
590 ATAXIA 59 0.0050
591 FEELING COLD 138 0.0050
592 STEVENS-JOHNSON SYNDROME 110 0.0049
593 METABOLIC ACIDOSIS 158 0.0049
594 DEAFNESS 129 0.0049
595 UPPER LIMB FRACTURE 98 0.0049
596 SUDDEN DEATH 52 0.0049
597 PAIN IN JAW 139 0.0049
598 BACTERAEMIA 58 0.0049
599 SYNOVITIS 88 0.0049
600 TOXICITY TO VARIOUS AGENTS 821 0.0049
601 PSYCHOLOGICAL TRAUMA 42 0.0049
602 DYSSTASIA 142 0.0049
603 PYELONEPHRITIS 42 0.0048
604 GINGIVAL BLEEDING 66 0.0048
605 ARTHRITIS 379 0.0048
606 MALAISE 2113 0.0048
607 MUSCLE ATROPHY 61 0.0048
608 PHARMACEUTICAL PRODUCT COMPLAINT 125 0.0048
609 HYPOPHAGIA 123 0.0048
610 LIP SWELLING 160 0.0048
611 EYE INFECTION 54 0.0048
612 TACHYPNOEA 65 0.0048
613 GENERAL PHYSICAL HEALTH DETERIORATION 553 0.0048
614 LUNG DISORDER 234 0.0048
615 INSOMNIA 1269 0.0048
616 THROMBOSIS 382 0.0047
617 ILEUS 59 0.0047
618 EMOTIONAL DISORDER 146 0.0047
619 FATIGUE 3679 0.0047
620 PAIN IN EXTREMITY 1388 0.0047
621 PETECHIAE 49 0.0047
622 HIP FRACTURE 151 0.0047
623 MUSCLE SPASMS 854 0.0046
624 PYREXIA 1610 0.0046
625 ENCEPHALOPATHY 114 0.0046
626 MUSCLE TWITCHING 107 0.0046
627 BLOOD ALKALINE PHOSPHATASE INCREASED 115 0.0046
628 NEPHROLITHIASIS 212 0.0046
629 BACK DISORDER 75 0.0046
630 LETHARGY 265 0.0046
631 HERNIA 89 0.0046
632 PERIPHERAL SWELLING 709 0.0046
633 DEEP VEIN THROMBOSIS 299 0.0046
634 ERUCTATION 89 0.0046
635 TENDONITIS 71 0.0046
636 SCIATICA 73 0.0046
637 PNEUMONIA ASPIRATION 114 0.0046
638 SWOLLEN TONGUE 142 0.0045
639 ABDOMINAL DISTENSION 473 0.0045
640 HEPATIC CIRRHOSIS 85 0.0045
641 SOMNOLENCE 910 0.0045
642 HAEMORRHAGE 470 0.0045
643 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
644 IRRITABLE BOWEL SYNDROME 96 0.0045
645 PANCREATITIS 236 0.0045
646 VERTIGO 272 0.0045
647 VOMITING 2093 0.0044
648 RHINORRHOEA 287 0.0044
649 ANOSMIA 64 0.0044
650 BEDRIDDEN 58 0.0044
651 DYSPHONIA 258 0.0044
652 SWELLING 412 0.0044
653 TREATMENT NONCOMPLIANCE 239 0.0044
654 ANGIOEDEMA 193 0.0044
655 MEMORY IMPAIRMENT 599 0.0044
656 HEADACHE 2733 0.0044
657 JOINT DISLOCATION 46 0.0043
658 DIARRHOEA 2801 0.0043
659 SLEEP DISORDER 305 0.0043
660 NAUSEA 3411 0.0043
661 STOMATITIS 260 0.0043
662 HALLUCINATION, AUDITORY 68 0.0043
663 HYPOACUSIS 184 0.0043
664 HEPATOMEGALY 42 0.0043
665 DRY MOUTH 346 0.0043
666 ABASIA 105 0.0042
667 SKIN DISCOLOURATION 195 0.0042
668 SINUSITIS 433 0.0042
669 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
670 BLOOD GLUCOSE INCREASED 792 0.0042
671 LIMB DISCOMFORT 130 0.0042
672 PANCREATITIS ACUTE 94 0.0042
673 POOR QUALITY SLEEP 90 0.0042
674 EATING DISORDER 89 0.0042
675 FLATULENCE 237 0.0042
676 QUALITY OF LIFE DECREASED 56 0.0042
677 IMPAIRED QUALITY OF LIFE 60 0.0042
678 BURNING SENSATION 292 0.0042
679 HYPOAESTHESIA 621 0.0041
680 ARTHRALGIA 1724 0.0041
681 NERVE INJURY 46 0.0041
682 CEREBRAL INFARCTION 101 0.0041
683 SLUGGISHNESS 42 0.0041
684 EAR PAIN 80 0.0041
685 ORAL PAIN 92 0.0041
686 SNEEZING 92 0.0041
687 NO THERAPEUTIC RESPONSE 50 0.0041
688 INTESTINAL OBSTRUCTION 154 0.0041
689 HEPATIC FAILURE 123 0.0041
690 GAIT DISTURBANCE 780 0.0041
691 NIGHT SWEATS 131 0.0041
692 SPEECH DISORDER 213 0.0041
693 BLOOD GLUCOSE ABNORMAL 75 0.0041
694 THROMBOCYTOPENIA 454 0.0041
695 NERVOUSNESS 212 0.0041
696 HYPERCALCAEMIA 50 0.0040
697 NEUROPATHY PERIPHERAL 385 0.0040
698 BREAST PAIN 43 0.0040
699 MYOCLONUS 48 0.0040
700 SEPTIC SHOCK 175 0.0040
701 BLOOD GLUCOSE DECREASED 193 0.0040
702 INFLUENZA 447 0.0040
703 FEELING ABNORMAL 958 0.0040
704 RESPIRATORY DISORDER 119 0.0040
705 BLINDNESS UNILATERAL 56 0.0040
706 ROAD TRAFFIC ACCIDENT 166 0.0040
707 PHARYNGEAL OEDEMA 61 0.0040
708 NASAL CONGESTION 233 0.0040
709 RENAL PAIN 42 0.0040
710 SHOCK 91 0.0040
711 SEROTONIN SYNDROME 76 0.0040
712 BLISTER 220 0.0039
713 PNEUMOTHORAX 62 0.0039
714 APHASIA 118 0.0039
715 JOINT SWELLING 469 0.0039
716 MYELODYSPLASTIC SYNDROME 56 0.0039
717 DRUG LEVEL INCREASED 64 0.0039
718 PANCYTOPENIA 216 0.0039
719 ELECTROCARDIOGRAM QT PROLONGED 139 0.0039
720 BIPOLAR DISORDER 42 0.0039
721 OROPHARYNGEAL PAIN 357 0.0039
722 SKIN HAEMORRHAGE 57 0.0038
723 RESPIRATORY ARREST 106 0.0038
724 DISTURBANCE IN ATTENTION 207 0.0038
725 MUSCULOSKELETAL DISORDER 73 0.0038
726 PLATELET COUNT INCREASED 50 0.0038
727 LIVER DISORDER 170 0.0038
728 GASTROINTESTINAL PAIN 42 0.0038
729 THROAT TIGHTNESS 103 0.0038
730 HOT FLUSH 284 0.0038
731 MUSCLE TIGHTNESS 61 0.0038
732 COLON CANCER 56 0.0038
733 DEPRESSED MOOD 198 0.0037
734 DYSKINESIA 152 0.0037
735 SENSORY DISTURBANCE 60 0.0037
736 GLYCOSYLATED HAEMOGLOBIN INCREASED 94 0.0037
737 SKIN LESION 102 0.0037
738 TOOTH INFECTION 49 0.0037
739 PHARYNGITIS 46 0.0037
740 SCAB 42 0.0037
741 LYMPHOCYTE COUNT DECREASED 65 0.0037
742 ARTHROPATHY 204 0.0037
743 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 175 0.0036
744 BLOOD BILIRUBIN INCREASED 98 0.0036
745 ABDOMINAL DISCOMFORT 607 0.0036
746 MOVEMENT DISORDER 116 0.0036
747 LOCAL SWELLING 63 0.0036
748 DELUSION 56 0.0036
749 THERAPY NON-RESPONDER 162 0.0036
750 NODULE 47 0.0036
751 ERECTILE DYSFUNCTION 92 0.0036
752 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
753 WEIGHT INCREASED 798 0.0036
754 COVID-19 PNEUMONIA 42 0.0036
755 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0035
756 PLATELET COUNT DECREASED 376 0.0035
757 PNEUMONITIS 95 0.0035
758 IMMUNODEFICIENCY 52 0.0035
759 PANIC ATTACK 127 0.0035
760 LYMPHADENOPATHY 123 0.0035
761 PRODUCT TASTE ABNORMAL 47 0.0035
762 THIRST 62 0.0035
763 FEEDING DISORDER 70 0.0034
764 COORDINATION ABNORMAL 48 0.0034
765 GASTRIC DISORDER 118 0.0034
766 THYROID DISORDER 53 0.0034
767 LOWER LIMB FRACTURE 66 0.0034
768 GASTROENTERITIS VIRAL 62 0.0034
769 MALIGNANT MELANOMA 46 0.0034
770 TOOTH DISORDER 76 0.0034
771 CONDITION AGGRAVATED 1037 0.0034
772 INSURANCE ISSUE 52 0.0034
773 JOINT STIFFNESS 89 0.0034
774 INTENTIONAL PRODUCT MISUSE 297 0.0034
775 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
776 THINKING ABNORMAL 63 0.0034
777 BONE PAIN 198 0.0034
778 PRURITUS 1298 0.0034
779 DRUG TOXICITY 46 0.0034
780 ILL-DEFINED DISORDER 204 0.0034
781 ALANINE AMINOTRANSFERASE INCREASED 206 0.0034
782 PARALYSIS 48 0.0033
783 DEVICE OCCLUSION 47 0.0033
784 GASTROINTESTINAL DISORDER 299 0.0033
785 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
786 BODY TEMPERATURE INCREASED 68 0.0033
787 IMPAIRED HEALING 109 0.0033
788 TASTE DISORDER 67 0.0033
789 THROAT IRRITATION 148 0.0033
790 DRUG INTOLERANCE 318 0.0033
791 MASS 46 0.0033
792 CONVULSION 188 0.0033
793 PARAESTHESIA 514 0.0033
794 MENTAL DISORDER 142 0.0033
795 MEDICATION ERROR 181 0.0033
796 PRODUCT PRESCRIBING ERROR 77 0.0032
797 APHONIA 45 0.0032
798 BRONCHOSPASM 46 0.0032
799 VISUAL ACUITY REDUCED 107 0.0032
800 VISUAL IMPAIRMENT 399 0.0032
801 NASOPHARYNGITIS 592 0.0032
802 CANDIDA INFECTION 54 0.0032
803 RESTLESSNESS 116 0.0032
804 FEELING HOT 194 0.0032
805 LUNG NEOPLASM MALIGNANT 130 0.0032
806 PROTEINURIA 60 0.0032
807 EYE PRURITUS 106 0.0032
808 TOOTHACHE 57 0.0031
809 ERYTHEMA 647 0.0031
810 EYE HAEMORRHAGE 42 0.0031
811 FLUSHING 319 0.0031
812 HEPATITIS 80 0.0031
813 FUNGAL INFECTION 104 0.0031
814 PHOTOSENSITIVITY REACTION 51 0.0031
815 ABDOMINAL PAIN LOWER 78 0.0031
816 EAR INFECTION 82 0.0031
817 PARANOIA 53 0.0031
818 DISEASE RECURRENCE 146 0.0031
819 SKIN DISORDER 101 0.0030
820 LUNG INFECTION 47 0.0030
821 PRURITUS GENERALISED 65 0.0030
822 HYPOAESTHESIA ORAL 45 0.0030
823 TARDIVE DYSKINESIA 84 0.0030
824 AGEUSIA 74 0.0030
825 DIABETIC KETOACIDOSIS 71 0.0030
826 HERPES ZOSTER 169 0.0029
827 INTENTIONAL DOSE OMISSION 83 0.0029
828 RASH MACULO-PAPULAR 64 0.0029
829 DEATH 2475 0.0029
830 NERVOUS SYSTEM DISORDER 89 0.0028
831 RASH MACULAR 99 0.0028
832 GAIT INABILITY 94 0.0028
833 CHOLESTASIS 54 0.0028
834 KNEE ARTHROPLASTY 59 0.0028
835 INFLAMMATION 144 0.0028
836 INTERSTITIAL LUNG DISEASE 135 0.0028
837 RASH PRURITIC 151 0.0028
838 PLASMA CELL MYELOMA 108 0.0028
839 EYE DISORDER 91 0.0028
840 THERAPY CESSATION 142 0.0028
841 VIRAL INFECTION 92 0.0028
842 DYSGEUSIA 205 0.0028
843 ABSCESS 44 0.0028
844 PAIN OF SKIN 74 0.0027
845 METASTASES TO BONE 45 0.0027
846 EXTRAPYRAMIDAL DISORDER 68 0.0027
847 INTENTIONAL PRODUCT USE ISSUE 239 0.0027
848 RASH 1187 0.0027
849 SWELLING FACE 177 0.0027
850 INFECTION 393 0.0027
851 LACRIMATION INCREASED 82 0.0027
852 COMPLETED SUICIDE 226 0.0027
853 COVID-19 475 0.0027
854 PRESCRIBED UNDERDOSE 54 0.0027
855 RASH GENERALISED 70 0.0027
856 TOOTH LOSS 56 0.0027
857 SURGERY 158 0.0027
858 RASH ERYTHEMATOUS 128 0.0027
859 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 145 0.0026
860 INTENTIONAL DRUG MISUSE 55 0.0026
861 IMPAIRED WORK ABILITY 56 0.0026
862 PRODUCT QUALITY ISSUE 355 0.0026
863 FEBRILE NEUTROPENIA 173 0.0026
864 LACTIC ACIDOSIS 84 0.0026
865 OSTEONECROSIS OF JAW 64 0.0026
866 THERAPEUTIC RESPONSE UNEXPECTED 115 0.0026
867 URTICARIA 429 0.0026
868 PERITONITIS 53 0.0026
869 C-REACTIVE PROTEIN INCREASED 93 0.0026
870 FACE OEDEMA 43 0.0025
871 DRY EYE 127 0.0025
872 OFF LABEL USE 2221 0.0025
873 CONJUNCTIVITIS 47 0.0025
874 HOSPITALISATION 387 0.0025
875 INCREASED APPETITE 48 0.0025
876 WHITE BLOOD CELL COUNT DECREASED 272 0.0025
877 CRYING 91 0.0025
878 EYE SWELLING 93 0.0025
879 BONE DENSITY DECREASED 78 0.0025
880 ABNORMAL DREAMS 68 0.0025
881 ANAPHYLACTIC REACTION 136 0.0025
882 SEIZURE 284 0.0025
883 PRODUCT DOSE OMISSION ISSUE 722 0.0025
884 LIVER INJURY 60 0.0024
885 CONTRAINDICATED PRODUCT ADMINISTERED 74 0.0024
886 INFLUENZA LIKE ILLNESS 201 0.0024
887 DEVICE DISLOCATION 106 0.0024
888 HEPATIC ENZYME INCREASED 166 0.0024
889 FEELING JITTERY 46 0.0024
890 DRUG ADMINISTRATION ERROR 74 0.0024
891 JAUNDICE 64 0.0024
892 MENTAL IMPAIRMENT 57 0.0023
893 DRUG INEFFECTIVE 3075 0.0023
894 PRODUCT USE IN UNAPPROVED INDICATION 577 0.0023
895 ANAPHYLACTIC SHOCK 60 0.0023
896 PSORIATIC ARTHROPATHY 94 0.0023
897 DISCOMFORT 141 0.0023
898 AGGRESSION 115 0.0023
899 FEMUR FRACTURE 71 0.0023
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 83 0.0023
901 MOUTH ULCERATION 48 0.0023
902 SUICIDAL IDEATION 208 0.0023
903 HYPERSENSITIVITY 420 0.0023
904 ABNORMAL BEHAVIOUR 89 0.0022
905 DERMATITIS 47 0.0022
906 DISEASE PROGRESSION 265 0.0022
907 DRUG PRESCRIBING ERROR 43 0.0022
908 RASH PAPULAR 50 0.0022
909 RHEUMATOID ARTHRITIS 253 0.0022
910 PRODUCT ADMINISTRATION ERROR 45 0.0022
911 NIGHTMARE 77 0.0022
912 ILLNESS 228 0.0022
913 DEVICE MALFUNCTION 154 0.0022
914 PRODUCT PHYSICAL ISSUE 44 0.0022
915 IRRITABILITY 131 0.0022
916 GLOSSODYNIA 48 0.0021
917 ANGER 72 0.0021
918 ADVERSE DRUG REACTION 189 0.0021
919 DRUG-INDUCED LIVER INJURY 66 0.0021
920 DRUG RESISTANCE 54 0.0021
921 PSYCHOTIC DISORDER 62 0.0021
922 OCULAR HYPERAEMIA 99 0.0021
923 THERAPY INTERRUPTED 147 0.0021
924 PRODUCT DOSE OMISSION IN ERROR 58 0.0020
925 NEOPLASM MALIGNANT 136 0.0020
926 THERAPEUTIC PRODUCT EFFECT DECREASED 91 0.0020
927 ADVERSE EVENT 186 0.0020
928 PRODUCT DOSE OMISSION 131 0.0020
929 ACCIDENTAL OVERDOSE 72 0.0020
930 INCORRECT DRUG ADMINISTRATION DURATION 55 0.0020
931 DRY SKIN 260 0.0019
932 MOOD SWINGS 62 0.0019
933 MOOD ALTERED 53 0.0019
934 PRODUCT USE ISSUE 360 0.0019
935 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 136 0.0019
936 SKIN EXFOLIATION 161 0.0019
937 DRUG EFFECT DECREASED 101 0.0019
938 PSORIASIS 243 0.0019
939 OSTEONECROSIS 61 0.0019
940 DRUG DOSE OMISSION 306 0.0018
941 EYE IRRITATION 104 0.0018
942 ALOPECIA 344 0.0017
943 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 315 0.0017
944 NEUTROPENIA 236 0.0017
945 SYSTEMIC LUPUS ERYTHEMATOSUS 61 0.0017
946 INJECTION SITE BRUISING 137 0.0017
947 OVERDOSE 370 0.0017
948 OESOPHAGEAL CARCINOMA 48 0.0016
949 DRUG ABUSE 133 0.0016
950 EXPIRED PRODUCT ADMINISTERED 53 0.0016
951 UNDERDOSE 114 0.0016
952 LEUKOPENIA 78 0.0016
953 ECZEMA 80 0.0015
954 PREMATURE BABY 46 0.0015
955 MALIGNANT NEOPLASM PROGRESSION 154 0.0015
956 INCORRECT DOSE ADMINISTERED 340 0.0015
957 PANCREATIC CARCINOMA 43 0.0015
958 PRODUCT SUBSTITUTION ISSUE 85 0.0015
959 WITHDRAWAL SYNDROME 60 0.0014
960 THERAPEUTIC RESPONSE SHORTENED 47 0.0014
961 EPILEPSY 43 0.0014
962 THERAPEUTIC RESPONSE DECREASED 85 0.0014
963 NEUTROPHIL COUNT DECREASED 56 0.0014
964 NEOPLASM PROGRESSION 47 0.0014
965 INJECTION SITE MASS 48 0.0013
966 DRUG EFFECT INCOMPLETE 47 0.0013
967 PRODUCT ADHESION ISSUE 46 0.0013
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 257 0.0013
969 EXTRA DOSE ADMINISTERED 48 0.0012
970 PROSTATE CANCER 92 0.0011
971 MULTIPLE SCLEROSIS 54 0.0011
972 SUICIDE ATTEMPT 66 0.0011
973 INJECTION SITE SWELLING 82 0.0011
974 INJECTION SITE HAEMORRHAGE 85 0.0011
975 SKIN BURNING SENSATION 72 0.0010
976 VAGINAL HAEMORRHAGE 42 0.0010
977 DEVICE DIFFICULT TO USE 64 0.0010
978 INJECTION SITE PAIN 296 0.0010
979 SKIN IRRITATION 44 0.0010
980 INTENTIONAL OVERDOSE 60 0.0009
981 MULTIPLE SCLEROSIS RELAPSE 64 0.0009
982 DEVICE ISSUE 82 0.0009
983 EXPOSURE DURING PREGNANCY 56 0.0009
984 DRUG WITHDRAWAL SYNDROME 79 0.0009
985 PRODUCT STORAGE ERROR 69 0.0008
986 TREATMENT FAILURE 65 0.0008
987 INJECTION SITE ERYTHEMA 95 0.0008
988 ACCIDENTAL EXPOSURE TO PRODUCT 76 0.0007
989 BREAST CANCER 68 0.0007
990 INJECTION SITE PRURITUS 48 0.0007
991 NO ADVERSE EVENT 126 0.0007
992 INJECTION SITE REACTION 45 0.0007
993 FOETAL EXPOSURE DURING PREGNANCY 45 0.0006
994 MATERNAL EXPOSURE DURING PREGNANCY 46 0.0005
995 DRUG DEPENDENCE 78 0.0005